| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/18/2006 | US20060104910 Over dosage indicating medicated film strip |
| 05/18/2006 | US20060104909 Abuse-resistant pharmaceutical compositions |
| 05/18/2006 | US20060103807 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 05/18/2006 | US20060102095 Bovine germicide application device and method |
| 05/18/2006 | DE3830494B4 Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe Water-soluble mono esters as solubilizers for pharmacologically active substances and pharmaceutical excipients |
| 05/18/2006 | DE10349979B4 Medikamentöse gezielte lokale Lipolyse Drug targeted local lipolysis |
| 05/18/2006 | CA2598433A1 Over dosage indicating medicated film strip |
| 05/18/2006 | CA2587470A1 Combination therapy associating preferably a ceramide with a cytotoxic drug |
| 05/18/2006 | CA2587392A1 Solid particles from controlled destabilisation of microemulsions |
| 05/18/2006 | CA2587376A1 Protein-noble metal nanoparticles |
| 05/18/2006 | CA2587295A1 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| 05/18/2006 | CA2587276A1 Nanoparticulate compositions of tubulin inhibitor compounds |
| 05/18/2006 | CA2586846A1 A stabilized polymeric delivery system |
| 05/18/2006 | CA2586798A1 Retinoid solutions and formulations made therefrom |
| 05/18/2006 | CA2586760A1 Stabilized ramipril compositions and methods of making |
| 05/18/2006 | CA2586447A1 Pharmaceutical analysis apparatus and method |
| 05/18/2006 | CA2586354A1 Liposome formulation of peptide boronic acids compounds |
| 05/18/2006 | CA2586348A1 Liposomal formulation of bortezomib (ps-341) |
| 05/18/2006 | CA2586152A1 Process for granulating particles |
| 05/18/2006 | CA2586124A1 Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives |
| 05/18/2006 | CA2586074A1 Ophthalmic oil-in-water type emulsion with stable positive zeta potential |
| 05/18/2006 | CA2585976A1 Novel composition for easing human childbirth |
| 05/18/2006 | CA2585974A1 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
| 05/18/2006 | CA2585760A1 Ophthalmic solution |
| 05/18/2006 | CA2585721A1 Non-gelatin soft capsule system |
| 05/18/2006 | CA2585606A1 High-dosage extended-release formulation of gepirone |
| 05/18/2006 | CA2585314A1 A process for preparing formulations of lipophilic active substances by spray freeze drying |
| 05/18/2006 | CA2585296A1 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 05/18/2006 | CA2584475A1 Extended surface aggregates in the treatment of skin conditions |
| 05/18/2006 | CA2584279A1 Compositions and methods for stabilizing liposomal drug formulations |
| 05/18/2006 | CA2584017A1 Aqueous ophthalmic suspension of crystalline rebamipide |
| 05/18/2006 | CA2578176A1 Ophthalmic emulsions containing an immunosuppressive agent |
| 05/17/2006 | EP1657265A1 Novel coating composition |
| 05/17/2006 | EP1656944A1 Cultivated agarwood |
| 05/17/2006 | EP1656940A1 Angiotensin II receptor antagonists for treating vascular headache conditions |
| 05/17/2006 | EP1656930A1 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 05/17/2006 | EP1656307A1 Micronutrient supplement dispensing package |
| 05/17/2006 | EP1656171A1 Substrates for drug delivery device and methods of preparing and use |
| 05/17/2006 | EP1656159A2 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 05/17/2006 | EP1656126A1 Preparing method for controlled released type tablet tamsulosin hcl and the tablet thereof |
| 05/17/2006 | EP1656122A1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 05/17/2006 | EP1656121A1 Biliquid foams, stable dispersions thereof and a corresponding process of manufacturing |
| 05/17/2006 | EP1656120A1 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases |
| 05/17/2006 | EP1656119A2 Pharmaceutical gelatine capsules |
| 05/17/2006 | EP1656118A2 Novel formulation of ropinirole |
| 05/17/2006 | EP1656117A1 Flavored taste-masked pharmaceutical formulation made using a one-step coating process |
| 05/17/2006 | EP1656116A2 Polymeric systems for controlled drug therapy |
| 05/17/2006 | EP1656115A2 Controlled release compositions |
| 05/17/2006 | EP1656114A1 Structured surfactant systems |
| 05/17/2006 | EP1656113A2 Method for the production of effervescent granules in a vacuum |
| 05/17/2006 | EP1656112A1 Buccal formulations of galanthamine and uses thereof |
| 05/17/2006 | EP1656102A2 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof |
| 05/17/2006 | EP1656099A1 Emulsions with a concentrated internal oil phase |
| 05/17/2006 | EP1656098A1 Concentrated oil-in-water emulsions |
| 05/17/2006 | EP1656031A2 Chewing gum and confectionery compositions containing a strain removing complex, and methods of making and using the same |
| 05/17/2006 | EP1656018A1 Edible films for administration of medicaments to animals |
| 05/17/2006 | EP1541042B1 Gel-type drink composition |
| 05/17/2006 | EP1507519B1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
| 05/17/2006 | EP1413174A4 Mounting arrangement for auxiliary burner or lance |
| 05/17/2006 | EP1372611B1 Pharmaceutical composition comprising a poorly water-soluble staurosporine, a surfactant and a water-soluble polymer |
| 05/17/2006 | EP1368002B1 Method for producing a floating tablet containing alfuzosine |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1307202B1 Method for the treatment of overactive bladder |
| 05/17/2006 | EP1276463A4 Hemostatic agent, method and carrier for applying a blood clotting agent |
| 05/17/2006 | EP1272220B1 Formulation for the prevention of cardiovascular disease |
| 05/17/2006 | EP1253903B1 Surfactant free topical compositions and method for rapid preparation thereof |
| 05/17/2006 | EP1200321B1 Valve with a valve stem wiper |
| 05/17/2006 | EP1197221B1 G-csf preparations stabilized over long time |
| 05/17/2006 | EP1161224B1 Device for releasing cosmetic active substances |
| 05/17/2006 | EP1141235B1 (bifidobacterium) in the treatment of inflammatory disease |
| 05/17/2006 | EP1115372B1 Fast dissolving orally consumable films |
| 05/17/2006 | EP1061987B1 Drug delivery system |
| 05/17/2006 | EP1035866B1 Mixed lipopeptide micelles for inducing an immune response and their therapeutic uses |
| 05/17/2006 | EP1007101B1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/17/2006 | EP0938900B1 Preventives/remedies for stomatitis |
| 05/17/2006 | CN2780235Y Instrument for treating kidney disease |
| 05/17/2006 | CN2780197Y Adhesive bandage for analgesic |
| 05/17/2006 | CN2780196Y Plaster for removing scar |
| 05/17/2006 | CN1774443A Phosphates of secondary alcohols |
| 05/17/2006 | CN1774414A New non-ionic surfactants for solubilizing poorly soluble molecules |
| 05/17/2006 | CN1774281A Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 05/17/2006 | CN1774263A Long acting injectable insulin composition and methods of making and using thereof |
| 05/17/2006 | CN1774261A Methods and compositions for the treatment of diseases of the eye |
| 05/17/2006 | CN1774259A Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 05/17/2006 | CN1774258A Treatment of pulmonary disease |
| 05/17/2006 | CN1774241A Oral drug delivery system comprising high viscosity liquid carrier materials |
| 05/17/2006 | CN1774240A Pharmaceutical composition containing levodopa and carbidopa |
| 05/17/2006 | CN1774239A Active drug delivery in the gastrointestinal tract |
| 05/17/2006 | CN1774238A Formulations and methods for treating rhinosinusitis |
| 05/17/2006 | CN1774237A Angiogenesis promotion by prostaglandin compositions and methods |
| 05/17/2006 | CN1772761A Serial cyclovirobuxine compounds as new medicine for preventing and treating cardiac vascular diseases and their prepn |
| 05/17/2006 | CN1772360A Menthol water dissolving technique and its application |
| 05/17/2006 | CN1772312A Wound dressing for first aid |
| 05/17/2006 | CN1772303A Nanometer magnetic powder-antibody targeting medicine for magneto thermical threrapy of malignant tumor |
| 05/17/2006 | CN1772302A Heat resistant freeze drying protectant for chicken Newcastle disease live vaccine and its prepn and application |
| 05/17/2006 | CN1772301A Nimodipine soft capsule and its prepn |
| 05/17/2006 | CN1772300A Nanometer manetic powder for magnetothermical therapy and anti-CEA antibody target medicine |
| 05/17/2006 | CN1772299A The pIL-4 gene adjuvant for pig vaccine and its prepn process |
| 05/17/2006 | CN1772297A The pIFN-gamma gene adjuvant for pig vaccine and its prepn process |
| 05/17/2006 | CN1772293A Composite hepatitis B virus surface antigen granule containing S1, S2 and S proantigen determinants |